Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: Significance of interleukin-6 synthesized by stromal cells in response to cancer cells

American Journal of Pathology

Volumn 176, Issue 2, 2010, Pages 968-980

  Kayamori, Kou ^a   Sakamoto, Kei ^a   Nakashima, Tomoki ^a   Takayanagi, Hiroshi ^a   Morita, Kei Ichi ^a   Omura, Ken ^a   Nguyen, Su Tien ^b   Miki, Yoshio ^a,b,c   Iimura, Tadahiro ^a   Himeno, Akiko ^a   Akashi, Takumi ^b   Yamada Okabe, Hisafumi ^d   Ogata, Etsuro ^d,e   Yamaguchi, Akira ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY HOSPITAL   (Japan)

^c CANCER INSTITUTE   (Japan)

^d CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^e CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE RELATED PROTEIN; VIMENTIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MALE; MICROARRAY ANALYSIS; MICROENVIRONMENT; MOUSE; MOUTH CANCER; NONHUMAN; NUDE MOUSE; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKULL; SQUAMOUS CELL CARCINOMA; STROMA CELL; XENOGRAFT;

EID: 76149087471     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090299     Document Type: Article

References (50)

1. Semba I, Matsuuchi H, Miura Y: Histomorphometric analysis of osteoclastic resorption in bone directly invaded by gingival squamous cell carcinoma. J Oral Pathol Med 1996, 25:429-435
2. Wong RJ, Keel SB, Glynn RJ, Varvares MA: Histological pattern of mandibular invasion by oral squamous cell carcinoma. Laryngoscope 2000, 110:65-72
3. Brown JS, Lowe D, Kalavrezos N, D'Souza J, Magennis P, Woolgar J: Patterns of invasion and routes of tumor entry into the mandible by oral squamous cell carcinoma. Head Neck 2002, 24:370-383
4. Shaw RJ, Brown JS, Woolgar JA, Lowe D, Rogers SN, Vaughan ED: The influence of the pattern of mandibular invasion on recurrence and survival in oral squamous cell carcinoma. Head Neck 2004, 26:861-869
5. Takayanagi H: Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007, 7:292-304
6. Boyce BF, Xing L: Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 2008, 473:139-146
7. Thomas GP, Baker SU, Eisman JA, Gardiner EM: Changing RANKL/ OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol 2001, 170:451-460
8. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176
9. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998, 95:3597-3602
10. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997, 89:309-319
11. Okamoto M, Hiura K, Ohe G, Ohba Y, Terai K, Oshikawa T, Furuichi S, Nishikawa H, Moriyama K, Yoshida H, Sato M: Mechanism for bone invasion of oral cancer cells mediated by interleukin-6 in vitro and in vivo. Cancer 2000, 89:1966-1975
12. Tada T, Jimi E, Okamoto M, Ozeki S, Okabe K: Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts. Int J Cancer 2005, 116:253-262
13. Shibahara T, Nomura T, Cui NH, Noma H: A study of osteoclastrelated cytokines in mandibular invasion by squamous cell carcinoma. Int J Oral Maxillofac Surg 2005, 34:789-793
14. Cui N, Nomura T, Noma H, Yokoo K, Takagi R, Hashimoto S, Okamoto M, Sato M, Yu G, Guo C, Shibahala T: Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice. Clin Cancer Res 2005, 11:2713-2719
15. 3 or parathyroid hormone. J Biol Chem 1999, 274:19301-19308
16. Jablonska E, Piotrowski L, Grabowska Z: Serum levels of IL-1β, IL-6, TNF-α, sTNF-RI and CRP in patients with oral cavity cancer. Pathol Oncol Res 1997, 3:126-129
17. Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, McCullagh L, Mousa S, Quezado M, Herscher LL, Van Waes C: Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 1999, 5:1369-1379
18. Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, Wolf GT, Teknos TN: Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer 2008, 113:750-757
19. Burtis WJ, Wu T, Bunch C, Wysolmerski JJ, Insogna KL, Weir EC, Broadus AE, Stewart AF: Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem 1987, 262:7151-7156
20. Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M, Nissenson RA: Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone, J Clin Invest 1987, 80:1803-1807
21. Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall RE, Kemp BE, Suva LJ, Rodda CP, Ebeling PR, Hudson PJ, Zajac JD, Martin TJ: Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA 1987, 84:5048-5052
22. Shulkes A, Fletcher DR, Rubinstein C, Ebeling PR, Martin TJ: Production of calcitonin gene related peptide, calcitonin and PTH-related protein by a prostatic adenocarcinoma. Clin Endocrinol (Oxf) 1991, 34:387-393
23. Malakouti S, Asadi FK, Kukreja SC, Abcarian HA, Cintron JR: Parathyroid hormone-related protein expression in the human colon: immunohistochemical evaluation. Am Surg 1996, 62:540-544; discussion 544-545
24. Dunne FP, Bowden SJ, Brown JS, Ratcliffe WA, Browne RM: Parathyroid hormone related protein in oral squamous cell carcinomas invading the mandible. J Clin Pathol 1995, 48:300-303
25. Tsuchimochi M, Kameta A, Sue M, Katagiri M: Immunohistochemical localization of parathyroid hormone-related protein (PTHrP) and serum PTHrP in normocalcemic patients with oral squamous cell carcinoma. Odontology 2005, 93:61-71
26. Kornberg LJ, Villaret D, Popp M, Lui L, McLaren R, Brown H, Cohen D, Yun J, McFadden M: Gene expression profiling in squamous cell carcinoma of the oral cavity shows abnormalities in several signaling pathways. Laryngoscope 2005, 115:690-698
27. Deyama Y, Tei K, Yoshimura Y, Izumiyama Y, Takeyama S, Hatta M, Totsuka Y, Suzuki K: Oral squamous cell carcinomas stimulate osteoclast differentiation. Oncol Rep 2008, 20:663-668
28. Roodman GD: Biology of osteoclast activation in cancer. J Clin Oncol 2001, 19:3562-3571
29. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449:557-563
30. Mishra PJ, Mishra PJ, Glod JW, Banerjee D: Mesenchymal stem cells: flip side of the coin. Cancer Res 2009, 69:1255-1258
31. Ishikuro M, Sakamoto K, Kayamori K, Akashi T, Kanda H, Izumo T, Yamaguchi A: Significance of the fibrous stroma in bone invasion by human gingival squamous cell carcinomas. Bone 2008, 43:621-627
32. Takagi N, Mihara M, Moriya Y, Nishimoto N, Yoshizaki K, Kishimoto T, Takeda Y, Ohsugi Y: Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum 1998, 41:2117-2121
33. Onuma E, Sato K, Saito H, Tsunenari T, Ishii K, Esaki K, Yabuta N, Wakahara Y, Yamada-Okabe H, Ogata E: Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy. Anticancer Res 2004, 24:2665-2673
34. Nguyen ST, Hasegawa S, Tsuda H, Tomioka H, Ushijima M, Noda M, Omura K, Miki Y: Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma. Cancer Sci 2007, 98:740-746
35. Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E, Takagishi K, Kato Y: Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 2001, 288:413-419
36. Kondo T, Kitazawa R, Yamaguchi A, Kitazawa S: Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels. J Cell Biochem 2008, 103:335-345
37. Guillén C, Martinez P, de Gortazar AR, Martinez ME, Esbrit P: Both Nand C-terminal domains of parathyroid hormone-related protein increase interleukin-6 by nuclear factor-kappa B activation in osteoblastic cells. J Biol Chem 2002, 277:28109-28117
38. Woods KV, El-Naggar A, Clayman GL, Grimm EA: Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res 1998, 58:3132-3141
39. Wang YF, Chang SY, Tai SK, Li WY, Wang LS: Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma. Head Neck 2002, 24:850-858
40. de la Mata J, Uy HL, Guise TA, Story B, Boyce BF, Mundy GR, Roodman GD: Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J Clin Invest 1995, 95:2846-2852
41. Sohara Y, Shimada H, Minkin C, Erdreich-Epstein A, Nolta JA, DeClerck YA: Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells. Cancer Res 2005, 65:1129-1135
42. Fukaya Y, Shimada H, Wang LC, Zandi E, DeClerck YA: Identification of galectin-3-binding protein as a factor secreted by tumor cells that stimulates interleukin-6 expression in the bone marrow stroma. J Biol Chem 2008, 283:18573-18581
43. Gunn WG, Conley A, Deininger L, Olson SD, Prockop DJ, Gregory CA: A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma. Stem Cells 2006, 24:986-991
44. Arnulf B, Lecourt S, Soulier J, Ternaux B, Lacassagne MN, Crinquette A, Dessoly J, Sciaini AK, Benbunan M, Chomienne C, Fermand JP, Marolleau JP, Larghero J: Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Leukemia 2007, 21:158-163
45. Roodman GD, Kurihara N, Ohsaki Y, Kukita A, Hosking D, Demulder A, Smith JF, Singer FR: Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone, J Clin Invest 1992, 89:46-52
46. Reddy SV, Takahashi S, Dallas M, Williams RE, Neckers L, Roodman GD: Interleukin-6 antisense deoxyoligonucleotides inhibit bone resorption by giant cells from human giant cell tumors of bone. J Bone Miner Res 1994, 9:753-757
47. Langub MC Jr, Koszewski NJ, Turner HV, Monier-Faugere MC, Geng Z, Malluche HH: Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy. Kidney Int 1996, 50:515-520
48. Riminucci M, Kuznetsov SA, Cherman N, Corsi A, Bianco P, Gehron Robey P: Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone 2003, 33:434-442
49. Roodman GD: Regulation of osteoclast differentiation. Ann NY Acad Sci 2006, 1068:100-109
50. O'Keefe RA, Teot LA, Singh D, Puzas JE, Rosier RN, Hicks DG: Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study. Lab Invest 1997, 76:457-465